Corporate ActionAug 5, 2026, 07:46 PM
Braveheart Bio Increases Common Stock Offering by 2.875M Shares
AI Summary
Braveheart Bio, Inc. filed an S-1MEF registration statement to increase the aggregate number of common stock shares offered. The company is increasing the offering by 2,875,000 shares, with 375,000 of these subject to the underwriters' option to purchase additional shares. This filing is made under Rule 462(b) and incorporates the prior S-1 registration statement (File No. 333-297456).
Key Highlights
- Increased common stock offering by 2,875,000 shares.
- 375,000 shares subject to underwriters' option.
- Filed S-1MEF under Rule 462(b) of the Securities Act.
- Incorporates prior S-1 registration statement (File No. 333-297456).
- Purpose is to increase aggregate shares for public sale.
Price Impact
More from BRVE